Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REHAB-2 long-term open-label study of YY001 for adult upper limb spasticity
CTR20260807Phase 3Active
- Sponsor
- Yuyan Pharma
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of YY001 in upper extremity spasticity, sponsored by Yuyan Pharma. Started Mar 2026; status: active.
02
Drugs
YY001
03
Conditions
upper extremity spasticity
Beyond the preview
Go deeper on CTR20260807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260807.